Can surgical management of bone metastases improve quality of life among women with gynecologic cancer?

Tao Ji, Ramez Eskander, Yifei Wang, Kunkun Sun, Bang H. Hoang, Wei Guo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The evaluation, counseling, and management of gynecologic patients with bone metastasis remain a challenge for clinicians. In order to critically evaluate the role of surgery, we retrospectively analyzed the records of 18 patients surgically treated for metastatic gynecologic tumors of bone, focusing on quality of life, local tumor control, and survival.Methods: Eighteen patients underwent surgical procedures for the treatment of bone metastases secondary to gynecologic cancer between September 2003 and April 2012. The primary cancer sites included the uterus (n = 10), the cervix (n = 5), and an ovary (n = 3). Patients were followed for an average period of 13.8 months (range, 2 to 34 months). A visual analog pain scale (VAS) and Eastern Cooperative Oncology Group (ECOG) performance status were evaluated both pre- and postoperatively.Results: The median survival time following diagnosis of bone metastasis was 10.0 months. The mean VAS score was 5.8 preoperatively compared with 2.1, 3 months after surgery. The mean pre and postoperative ECOG performance status grades were 3.1 and 2.3, respectively.Conclusions: The prognosis of gynecological cancer patients with bone metastasis is poor. Some patients had improvement in their quality of life after surgical intervention for bone metastases; however, novel integrated treatment modalities should be investigated.

Original languageEnglish (US)
Article number2500805
JournalWorld Journal of Surgical Oncology
Volume12
Issue number1
DOIs
StatePublished - Aug 5 2014
Externally publishedYes

Fingerprint

Quality of Life
Neoplasm Metastasis
Bone and Bones
Neoplasms
Pain Measurement
Survival
Cervix Uteri
Uterus
Counseling
Ovary
Therapeutics

Keywords

  • bone metastasis
  • gynecological cancer
  • palliative treatment
  • quality of life
  • surgery

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Medicine(all)

Cite this

Can surgical management of bone metastases improve quality of life among women with gynecologic cancer? / Ji, Tao; Eskander, Ramez; Wang, Yifei; Sun, Kunkun; Hoang, Bang H.; Guo, Wei.

In: World Journal of Surgical Oncology, Vol. 12, No. 1, 2500805, 05.08.2014.

Research output: Contribution to journalArticle

@article{0ab93d5d4b754cb2b02af513377efc62,
title = "Can surgical management of bone metastases improve quality of life among women with gynecologic cancer?",
abstract = "Background: The evaluation, counseling, and management of gynecologic patients with bone metastasis remain a challenge for clinicians. In order to critically evaluate the role of surgery, we retrospectively analyzed the records of 18 patients surgically treated for metastatic gynecologic tumors of bone, focusing on quality of life, local tumor control, and survival.Methods: Eighteen patients underwent surgical procedures for the treatment of bone metastases secondary to gynecologic cancer between September 2003 and April 2012. The primary cancer sites included the uterus (n = 10), the cervix (n = 5), and an ovary (n = 3). Patients were followed for an average period of 13.8 months (range, 2 to 34 months). A visual analog pain scale (VAS) and Eastern Cooperative Oncology Group (ECOG) performance status were evaluated both pre- and postoperatively.Results: The median survival time following diagnosis of bone metastasis was 10.0 months. The mean VAS score was 5.8 preoperatively compared with 2.1, 3 months after surgery. The mean pre and postoperative ECOG performance status grades were 3.1 and 2.3, respectively.Conclusions: The prognosis of gynecological cancer patients with bone metastasis is poor. Some patients had improvement in their quality of life after surgical intervention for bone metastases; however, novel integrated treatment modalities should be investigated.",
keywords = "bone metastasis, gynecological cancer, palliative treatment, quality of life, surgery",
author = "Tao Ji and Ramez Eskander and Yifei Wang and Kunkun Sun and Hoang, {Bang H.} and Wei Guo",
year = "2014",
month = "8",
day = "5",
doi = "10.1186/1477-7819-12-250",
language = "English (US)",
volume = "12",
journal = "World Journal of Surgical Oncology",
issn = "1477-7819",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Can surgical management of bone metastases improve quality of life among women with gynecologic cancer?

AU - Ji, Tao

AU - Eskander, Ramez

AU - Wang, Yifei

AU - Sun, Kunkun

AU - Hoang, Bang H.

AU - Guo, Wei

PY - 2014/8/5

Y1 - 2014/8/5

N2 - Background: The evaluation, counseling, and management of gynecologic patients with bone metastasis remain a challenge for clinicians. In order to critically evaluate the role of surgery, we retrospectively analyzed the records of 18 patients surgically treated for metastatic gynecologic tumors of bone, focusing on quality of life, local tumor control, and survival.Methods: Eighteen patients underwent surgical procedures for the treatment of bone metastases secondary to gynecologic cancer between September 2003 and April 2012. The primary cancer sites included the uterus (n = 10), the cervix (n = 5), and an ovary (n = 3). Patients were followed for an average period of 13.8 months (range, 2 to 34 months). A visual analog pain scale (VAS) and Eastern Cooperative Oncology Group (ECOG) performance status were evaluated both pre- and postoperatively.Results: The median survival time following diagnosis of bone metastasis was 10.0 months. The mean VAS score was 5.8 preoperatively compared with 2.1, 3 months after surgery. The mean pre and postoperative ECOG performance status grades were 3.1 and 2.3, respectively.Conclusions: The prognosis of gynecological cancer patients with bone metastasis is poor. Some patients had improvement in their quality of life after surgical intervention for bone metastases; however, novel integrated treatment modalities should be investigated.

AB - Background: The evaluation, counseling, and management of gynecologic patients with bone metastasis remain a challenge for clinicians. In order to critically evaluate the role of surgery, we retrospectively analyzed the records of 18 patients surgically treated for metastatic gynecologic tumors of bone, focusing on quality of life, local tumor control, and survival.Methods: Eighteen patients underwent surgical procedures for the treatment of bone metastases secondary to gynecologic cancer between September 2003 and April 2012. The primary cancer sites included the uterus (n = 10), the cervix (n = 5), and an ovary (n = 3). Patients were followed for an average period of 13.8 months (range, 2 to 34 months). A visual analog pain scale (VAS) and Eastern Cooperative Oncology Group (ECOG) performance status were evaluated both pre- and postoperatively.Results: The median survival time following diagnosis of bone metastasis was 10.0 months. The mean VAS score was 5.8 preoperatively compared with 2.1, 3 months after surgery. The mean pre and postoperative ECOG performance status grades were 3.1 and 2.3, respectively.Conclusions: The prognosis of gynecological cancer patients with bone metastasis is poor. Some patients had improvement in their quality of life after surgical intervention for bone metastases; however, novel integrated treatment modalities should be investigated.

KW - bone metastasis

KW - gynecological cancer

KW - palliative treatment

KW - quality of life

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=84905852267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905852267&partnerID=8YFLogxK

U2 - 10.1186/1477-7819-12-250

DO - 10.1186/1477-7819-12-250

M3 - Article

VL - 12

JO - World Journal of Surgical Oncology

JF - World Journal of Surgical Oncology

SN - 1477-7819

IS - 1

M1 - 2500805

ER -